A New Blood Type Discovery Stuns Doctors—and the World

A woman living on the French Caribbean island of Guadeloupe has been identified as carrying an extraordinarily rare blood type, so rare that doctors say no compatible donor exists anywhere on Earth. The discovery came during routine tests before surgery, when medical staff observed that her blood reacted negatively with every known blood type.

Her case marks the discovery of a newly classified blood group, now referred to as “Gwada Negative,” making it the 48th recognized human blood type worldwide. Most people are familiar with the ABO and Rh blood groups, but in reality, the human body can express over 360 different blood group antigens, leading to dozens of rare blood types.

According to the International Society of Blood Transfusion (ISBT), there are 44 recognized blood group systems as of 2024, including rare ones like Rhnull, the so-called “Golden Blood.” Gwada Negative has now been added to this growing list.

What makes this case so unusual is that even her own siblings were not a match, a fact confirmed by the hospital’s transfusion team. Further testing revealed that she lacks specific antigens present in all known blood donor registries, making transfusion nearly impossible.

Genetic sequencing identified a mutation in the PIGZ gene, which affects the glycosylphosphatidylinositol (GPI) anchor—a molecule that helps attach proteins to the surface of red blood cells. According to a 2023 paper published in Transfusion Medicine Reviews, mutations in GPI-related genes are “extremely rare but medically significant, particularly in transfusion compatibility and fetal-maternal interactions.”

This may explain another tragic element of the case: the woman has reportedly had two stillbirths, which doctors now suspect were caused by immune system incompatibility between her blood and that of her unborn children. Similar outcomes have been documented in mothers with rare blood antigens, particularly in cases where maternal antibodies attack fetal red blood cells.

Because there are no known compatible donors, her survival may depend on the future of lab-created blood. According to the UK’s National Health Service (NHS), scientists are already experimenting with lab-grown red blood cells for use in patients with rare blood types. In a 2022 NHS statement, researcher Dr. Farrukh Shah explained:

“This world-leading research lays the groundwork for the future of transfusion medicine. The need for normal blood donations to provide the vast majority will remain, but the potential for these lab-grown cells to treat those with rare blood types is very significant.”

Though Gwada Negative blood is known to exist in only this single patient, rare blood types have long been both a challenge and a breakthrough in medicine. Type O Negative, often called the universal donor type, is relatively uncommon—found in about 7 percent of the U.S. population—but is still widely used in emergencies.

Even rarer are types like Rhnull, sometimes referred to as “Golden Blood,” with only around 50 known cases worldwide. Its complete lack of Rh antigens makes it compatible with almost any blood type, making it invaluable for patients with extremely rare profiles and a critical tool for scientific research.

Another unusual type, Bombay phenotype, or hh blood type, is found in about 179 confirmed cases, mostly in India. Lacking the H antigen, Bombay blood can be donated to people with type A, B, AB, or O, but recipients with the Bombay type can only receive blood from others who share the same rare trait. As a result, blood banks in India actively track and store this type to avoid fatal mismatches.

Other rare types are not only significant for compatibility but for their connection to specific health conditions. Ro Kell-negative blood, found in about 2 percent of donors—especially in African American communities—is essential for treating sickle cell disease and is in constant demand. Likewise, Duffy-negative and U-negative blood types, more common in African and Middle Eastern populations, have proven value in transfusions and also offer natural resistance to certain forms of malaria.

As researchers continue studying the Gwada Negative blood type, they hope its unique characteristics could unlock insights into fetal blood rejection, rare antigen expression, and immune system reactions. The woman’s case remains under close monitoring as medical teams explore whether synthetic blood or gene-targeted therapies could offer a long-term solution.

While she may be the only known person with this blood type, the impact of her case could stretch far beyond her own survival. It’s a reminder that blood, at its most basic level, is anything but simple—and that each rare case brings medicine one step closer to understanding the full range of human biology.